Karen Matevosyan, MD

Assistant Professor
Pathology
Download Curriculum Vitae

Contact Information

UT Southwestern Medical Center
5323 Harry Hines Boulevard
Dallas, Texas 75390

Office Phone: 214-648-7886
Office Fax: 214-648-8037

karen.matevosyan@utsouthwestern.edu

To make an appointment, call 214-645-8300.

Education

FellowshipUT Southwestern Medical Center at Dallas (2008)
ResidencyUT Southwestern Medical Center at Dallas (2006)
InternshipAzerbaijan State Medical Institute (1982)
Medical SchoolAzerbaijan Med INST, BAKU (1981)

Publications

Use (and Misuse) of Plasma in Clinical Practice.

K. Matevosyan , Check Sample: Transfusion Medicine , January 2007; Vol. 50; No. TM 07-1:ISSN 1056-5949

Advantages of Isovolemic Hemodilution-Red Cell Exchange Therapy to Prevent Recurrent Stroke in Sickle Cell Anemia Patients.

Sarode R, Matevosyan K, Rogers Z , Burner J, Rutherford C, Journal of Clinical Apheresis, 2011; 26

Rapid Warfarin Reversal: A Three-factor Prothrombin Complex Concentrate and Recombinant Factor FVIIa Cocktail for Intracranial Hemorrhage.

Sarode R, Matevosyan K, Bhagat R, Beshay J, Rutherford C, Madden C, Journal of Neurosurgery, 2011; (DOI: 10.3171/2011.11.JNS11836):1-7

Coagulation factor levels in neurosurgical patients with mild prolongation of prothrombin time: Effect on plasma transfusion therapy.

Matevosyan K, Madden C, Barnett SL, Beshay J, Rutherford C, Sarode R, Journal of Neurosurgery, 2011; 114:3-7

Prospective Monitoring of Plasma and Platelet Transfusions in a Large Teaching Hospital Results in Significant Cost Reduction.

Sarode R, Refaai MA, Matevosyan K, Burner JD, Hampton S, Rutherford C, Transfusion, 2010; 50:487-492

Rinseback during red blood cell exchange with COBE Sprectra does not affect fraction of cells remaining (FCR) or post-exchange hematocrit.

Bhagat R, Matevosyan K, Jones R, Vetus ML, Burner JD, Sarode R, Journal of Clinical Apheresis, 2010; 25:347-349

Prothrombin complex concentrate and fatal thrombosis: poor evidence to implicate a relatively safe drug.

Sarode R, Matevosyan K, Annals of Emergency Medicine, 2009; 54:481-482

Is it quinine TTP/HUS or quinine TMA? ADAMTS13 levels and implications for therapy.

Park YA, Hay SN, King KE, Matevosyan K, Poisson J, Powers A, Sarode R, Shaz B, Brecher M, Journal of Clinical Apheresis, 2009; 24:115-119

Higher Optical Density of an Antigen Assay Predicts Thrombosis in Patients with Heparin Induced Thrombocytopenia.

F Altuntas, K Matevosyan, YM Shen, J Burner, R Sarode , European Journal of Haematology , 2008; (80):429-435

Delayed-Onset Heparin-Induced Thrombocytopenia, Venous Thromboembolism, and Cerebral Venous Thrombosis: A Consequence of Heparin "Flushes".

MA Refaai, TE Warkentin, M Axelson, K Matevosyan and R Sarode , Journal of Thrombosis and Haemostasis , 2007; (98):1139-1140

Professional Associations/Affiliations

American Association of Blood Banks

(2008)

American Society of Hematology

(2007)

North Texas Society of Pathologists

(2005)

American Society for Apheresis

(2004)

American Society of Clinical Pathologists

(2004)

College of American Pathology

(2004)